Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Long-Term Investments (2023 - 2024)

Historic Long-Term Investments for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q4 2024 value amounting to $39.5 million.

  • Zhengye Biotechnology Holding's Long-Term Investments rose 431.83% to $39.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $39.5 million, marking a year-over-year increase of 431.83%. This contributed to the annual value of $38.9 million for FY2024, which is 76.24% up from last year.
  • As of Q4 2024, Zhengye Biotechnology Holding's Long-Term Investments stood at $39.5 million, which was up 431.83% from $37.9 million recorded in Q4 2023.
  • Over the past 5 years, Zhengye Biotechnology Holding's Long-Term Investments peaked at $39.5 million during Q4 2024, and registered a low of $37.9 million during Q4 2023.